ACADIA Pharmaceuticals Inc (ACAD): Forvard P/E multiplikatori
ACADIA Pharmaceuticals Nuplazid ga tegishli patent nizolarini boshqarishni tor doiradagi bozor segmentini egallash strategiyasi bilan birlashtiradi. Kompaniyaning prognoz qilingan P/E ko'rsatkichi baholash dinamikasini aks ettiradi va joriy metrika 17.50 darajasida turibdi. Uning kamyob kasalliklar dori vositalari bo'yicha monopol narx belgilash imkoniyati eksklyuziv huquqlari muddati tugaguncha biznesga barqarorlikni ta'minlaydi.
ACADIA Pharmaceuticals kompaniyasining tahliliy kesimlari
- kotirovkalar va tahlilchilar prognozi:
- birja kapitallashuvi ma'lumotlari:
- balans kapitallashuvi haqida ma'lumot:
- kompaniyaning majburiyatlari va likvidligi ma'lumotlari:
Umumiy qarzning kapitalga nisbati ACADIA Pharmaceuticals|ACAD - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati ACADIA Pharmaceuticals|ACAD - Jamlangan qarz majburiyatlari|Qarzning balans kapitallashuviga nisbati ACADIA Pharma|ACAD - Uzoq muddatli majburiyatlar|Kompaniyaning qisqa muddatli qarzlari ACADIA Pharmaceuticals|Tezkor likvidlik koeffitsiyenti acadia-pharm.com
- foyda va bozor koeffitsiyentlari statistikasi:
ACAD - Sof foyda|Kutilayotgan foyda ACADIA Pharmaceuticals|ACAD - Kompaniya qiymatining sof foydaga nisbati|Kelajakdagi narxning foydaga nisbati ACADIA Pharmaceuticals Inc|ACAD - Narx-foyda va o‘sish multiplikatori|EV/EBITDA multiplikatori ACADIA Pharma|ACAD - EBITDA operatsion foydasi|Bir aksiya uchun sof foyda (EPS TTM) ACADIA Pharmaceuticals|ACAD - So'nggi 12 oy davomida bir aksiya uchun sof foyda|Choraklik EPS foyda o'sishi acadia-pharm.com|ACAD - Joriy yilda bir aksiya uchun foydaning o'sish sur'ati|Keyingi yil uchun bir aksiya uchun kutilayotgan foyda o'sishi ACADIA Pharmaceuticals
Fundamental baholash:ACAD ACADIA Pharmaceuticals Inc.
Forward P/E ko'rsatkichi aksiyaning joriy bozor qiymatining prognoz qilingan bir aksiya uchun foydasi nisbati sifatida hisoblanadi va bozarning kelajakdagi pul oqimlari uchun premium to'lashga bo'lgan tayyorligini o'lchaydi. ACADIA Pharmaceuticals (ACAD) uchun kompaniyaning kelajakdagi narx-foyda koeffitsiyenti trayektoriyasi uning Markaziy Nerv Tizimi (CNS) bo'yicha biotexnologik yechimlari kengayishiga bo'lgan kutishlarni aks ettiradi, bunda past ishlab chiqarish xarajatlarining global patent qamrovi bilan birlashishi sof foydaning tez o'sishini ta'minlashi kerak.
ACADIA Pharmaceuticals raqobatchilari tahlili
Forvard P/E multiplikatori BIIB|Prognoz qilingan narxning foydaga nisbati Neurocrine NBIX|Forvard P/E multiplikatori RGC (Regencell)|Forvard P/E multiplikatori Axsome Corp AXSM|Xenon Pharmaceuticals - Forvard P/E multiplikatori|VKTX (vikingtherapeutics.com) - Narxning kelajakdagi foydaga nisbati|SUPN: Forvard P/E multiplikatori|CPRX - Kapitalizatsiyaning prognoz qilingan foydaga nisbati|DNLI (Denali Therapeutics Inc) - Forvard P/E multiplikatori|Forvard P/E multiplikatori Harmony Corp|Prognoz qilingan narxning foydaga nisbati BHVN (Biohaven Ltd.)|AMLX (amylyx.com) - Kelajakdagi narx-foyda multiplikatori|Kelajakdagi narxning foydaga nisbati Trevi Therapeutics, Inc. TRVI|PRAX (Praxis Precision Medicines Inc) - Narxning kutilayotgan foydaga nisbati|Anavex Corp - Forvard P/E multiplikatori|Kelajakdagi narx-foyda multiplikatori CBLL (CeriBell EEG)|PRTA: Forvard P/E multiplikatori|Alector (ALEC) - Forvard P/E multiplikatori|Kelajakdagi narxning foydaga nisbati Annexon|OMER: Kelajakdagi narx-foyda multiplikatori|Kelajakdagi narxning foydaga nisbati Neurogene Corp (NGNE)|Prognoz qilingan narxning foydaga nisbati AC Immune Inc ACIU|Forvard P/E multiplikatori VYGR (Voyager Therapeutics)|Forvard P/E multiplikatori neumoratx.com NMRA|Scilex - Forvard P/E multiplikatori|Tevogen Bio Holdings Inc. (TVGN) - Prognoz qilingan narxning foydaga nisbati|ACOG: Forvard P/E multiplikatori|Prognoz qilingan narx-foyda nisbati Cognition Therapeutics Inc. (CGTX)|Prognoz qilingan narxning foydaga nisbati IKT|Forvard P/E multiplikatori cassavasciences.com|Prognoz qilingan narxning foydaga nisbati ASRT (Assertio Holdings, Inc.)|Kapitalizatsiyaning kelajakdagi foydaga nisbati COYA|Forvard P/E multiplikatori VTGN (Vistagen)|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Ovid Therapeutics Inc (OVID)|Acumen Pharmaceuticals - Forvard P/E multiplikatori|cervomed.com (CRVO) - Prognoz qilingan narxning foydaga nisbati|ATHE: Forvard P/E multiplikatori|Clene (CLNN) - Forvard P/E multiplikatori|Kelajakdagi narxning foydaga nisbati PepGen Inc|Kelajakdagi narxning foydaga nisbati JUNS|Kelajakdagi narxning foydaga nisbati Relmada Therapeutics (RLMD)|Kapitalizatsiyaning prognoz qilingan foydaga nisbati annovisbio.com|Forvard P/E multiplikatori GRCE (Grace Therapeutics)|Forvard P/E multiplikatori Firefly Neuroscience, Inc. AIFF|ANEW Medical, Inc. - Forvard P/E multiplikatori|NeuroSense Therapeutics (NRSN) - Prognoz qilingan narxning foydaga nisbati|RVPH: Forvard P/E multiplikatori|MetaVia (MTVA) - Forvard P/E multiplikatori|NRXS (NeurAxis) - Forvard P/E multiplikatori|Narxning kelajakdagi foydaga nisbati HSDT (Helius Medical Technologies Inc.)|Kelajakdagi narxning foydaga nisbati Passage Bio, Inc. (PASG)|bionomics.com.au - Narxning kelajakdagi foydaga nisbati|Forvard P/E multiplikatori NERV (Minerva Neurosciences)|athira.com (ATHA) - Prognoz qilingan narx-foyda nisbati|ADXN: Prognoz qilingan narxning foydaga nisbati|ALZN - Forvard P/E multiplikatori|cyclerion.com (CYCN) - Kelajakdagi narxning foydaga nisbati|Protagenic Therapeutics, Inc. - Kelajakdagi narx-foyda multiplikatori|Kelajakdagi narxning foydaga nisbati Pasithea Therapeutics Corp|Prognoz qilingan narx-foyda nisbati Cortigent Medical CRGT|Forvard P/E multiplikatori ATXI|Forvard P/E multiplikatori Brainstorm Cell Therapeutics Inc. (BCLI)|Forvard P/E multiplikatori CARA (Cara Therapeutics, Inc)|CHRO - Prognoz qilingan narxning foydaga nisbati|Eliem - Forvard P/E multiplikatori|ITCI - Forvard P/E multiplikatori|LBPH: Forvard P/E multiplikatori|Narxning kelajakdagi foydaga nisbati MRNS|NKGN (NKGen) - Forvard P/E multiplikatori|NeuroBo Pharma (NRBO) - Kapitalizatsiyaning prognoz qilingan foydaga nisbati|Forvard P/E multiplikatori SAGE|Forvard P/E multiplikatori synaptogen.com (SNPX)|Trevena - Prognoz qilingan narxning foydaga nisbati|Kelajakdagi narx-foyda multiplikatori VIGL|WENA - Kelajakdagi narxning foydaga nisbati|Narxning kutilayotgan foydaga nisbati CERE
